Ronin Gaming Altcoin Skyrockets Following Binance Listingby John Darbie 20.02.2024The web3 gaming altcoin PIXEL has surged over 46% after securing a listing on Binance, the world's leading cryptocurrency exchange.
Big Tech Firms Pledge to Fight AI Misuse in 2024 Voteby Lilu Anderson 20.02.2024A group of 20 leading technology companies have signed an agreement to combat harmful AI-generated content, like deepfakes, in order ...
Starbucks vs. Independent Cafés: Coffee Shop Market Dynamics SWOT Analysisby Mark Eisenberg 20.02.2024The battle between Starbucks and independent cafés heats up! Dive into the competitive coffee market with a detailed SWOT analysis. ...
6 KC Firms on Forbes’ Best Employers Listby Mark Eisenberg 20.02.2024Garmin and H&R Block, two Kansas City-area companies, made it to Forbes' top 10 best employers in the U.S. with ...
Google Unveils Gemini 1.5 to Rival OpenAIby Lilu Anderson 20.02.2024Gemini 1.5 pro, the improved version of the tech, is set to be released soon. It offers better performance and ...
Vision Pros Return Reports: The Truth Behind the Hypeby Lilu Anderson 20.02.2024High-profile Apple fans have reportedly returned their Vision Pros, but many others are happy with the product. Apple isn't worried ...
Master Negotiator Matt Schulz Shares Secrets to Financial Successby Mark Eisenberg 20.02.2024Personal finance expert Matt Schulz discusses how individuals can negotiate better deals for mortgages, car loans, and student loans in ...
Bitcoin Halving Impact on Top Altcoins: ApeMax, Sei, Solana, Stacks, Ethereum, Mina, Flowby John Darbie 19.02.2024The Bitcoin halving event is set to reshape the crypto landscape and shine a spotlight on altcoins like ApeMax, Sei, ...
Conquering Devastators in Helldivers 2by Lilu Anderson 19.02.2024Learn how to find and defeat Devastators in Helldivers 2 with Insider Gaming's guide. Use armor-piercing weapons or a powerful ...
Medicxi Launches Alys Pharmaceuticals in $100m Seed Fundingby Mark Eisenberg 19.02.2024Medicxi launches Alys Pharmaceuticals with $100m funding to develop groundbreaking therapies in immunodermatology. The company aims to address unmet needs ...